Product Information
APLISOL 5T UNIT/0.1 ML VIAL is a brand product labeled by Endo USA Inc., priced at $120.4534 per ML under NDC 42023010401. Its NADAC has been published 666 times since Nov 28, 2013.
Strength
5 [iU]/.1mL
Manufacturer
Endo USA Inc.NDC
42023010401
Classification
Brand
Dosage Form
INJECTION
Route
INTRADERMAL
Effective Date
9/23/2026
Active Ingredients
TUBERCULIN PURIFIED PROTEIN DERIVATIVEApproval Type
Biologic (BLA)
FDA Application
BLA103782On Market Since
4/25/2008
Pharmacological Classes
Price Statistics
The NADAC for APLISOL 5T UNIT/0.1 ML VIAL has been published 666 times since Nov 28, 2013, and over the history we have for it it has risen 205.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $120.4534 per ML |
|---|---|
| All-time high | $120.8397 (Jun 10, 2026) |
| All-time low | $35.8359 (Mar 19, 2014) |
| 52-week high | $120.8397 |
| 52-week low | $108.5028 |
| Median price | $82.7525 |
| Average price | $77.5817 |
| Largest weekly change | +21.3% (Jul 8, 2015) |
| Weeks tracked | 666 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tuberculin Purified Protein Derivative market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of APLISOL 5T UNIT/0.1 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for APLISOL 5T UNIT/0.1 ML VIAL, manufactured by Endo USA Inc., is $120.4534 per ML (NDC 42023010401), effective Sep 30, 2026.
How has the price of APLISOL 5T UNIT/0.1 ML VIAL changed over time?
Over the history we have for it, the NADAC for APLISOL 5T UNIT/0.1 ML VIAL has risen 205.3%. It has been tracked across 666 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for APLISOL 5T UNIT/0.1 ML VIAL?
Since Nov 28, 2013, the NADAC for APLISOL 5T UNIT/0.1 ML VIAL has ranged from a low of $35.8359 (Mar 19, 2014) to a high of $120.8397 (Jun 10, 2026), with a median of $82.7525 per ML.
Are there cheaper alternatives to APLISOL 5T UNIT/0.1 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, APLISOL 5T UNIT/0.1 ML VIAL, is $94.8687 per ML — about 21% below APLISOL 5T UNIT/0.1 ML VIAL.
Who manufactures APLISOL 5T UNIT/0.1 ML VIAL?
APLISOL 5T UNIT/0.1 ML VIAL (NDC 42023010401) is labeled by Endo USA Inc., and CMS classifies it as a brand product.